Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study

Yuankai Shi,Baolan Li,Lin Wu,Yueyin Pan,Zhijie Pan,Yunpeng Liu,Yun Fan,Yinghua Ji,Jian Fang,Qin Shi,Jianhua Shi,Hongjun Gao,Yanping Hu,Xiang Wang,Zhiyong He,Rui Ma,Yu Zhang,Da Jiang,Yuansong Bai,Yi Zhang,Linian Huang,Tong Zhou,Hailong Liu,Daqing Wang,Qinglian Wen,Gongyan Chen,Aimin Zang,Xiuwen Wang,Xinri Zhang,Jianbing Hu,Runxiang Yang,Guojun Zhang,Kangsheng Gu,Lin Wang,Qiming Wang,Zonghui Wei,Zeng Li,Hongda Lu,Helong Zhang,Hongyu Chen,Tingting Song

Journal of Thoracic Oncology（2022）

Cited 14|Views38
No score
Abstract
NCT03502850.
More
Translated text
Key words
Limertinib,ASK120067,EGFR T790M mutation,Third-generation EGFR-TKI
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined